Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | BCR | P11274 | 1/20 | 0.36 |
| ▸ | USP7 | Q93009 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10028790 | 0.80 | PTGS1 (0.41) | KIF11 | |
| SCHEMBL14648803 | 0.79 | PTGS2 (0.39) | RPS6KA3ABCB1 | |
| SCHEMBL8463553 | 0.78 | ALOX5AP (0.44) | ESR2HSD17B10CYP2C9CYP2C19BCL2L1 | |
| SCHEMBL30694739 | 0.78 | ESR1 (0.48) | ESR1ESR2HSD17B10ABL1ABCB1 | |
| SCHEMBL8831992 | 0.78 | ESR1 (0.48) | ESR1ESR2HSD17B10ABL1ABCB1 | |
| SCHEMBL1513625 | 0.78 | ESR1 (0.43) | ESR1ESR2RPS6KA3HSD17B10ABL1 | |
| SCHEMBL17859609 | 0.78 | PTGS2 (0.38) | RPS6KA3 | |
| SCHEMBL172128 | 0.77 | ACHE (0.56) | ESR1ESR2RPS6KA3USP7 | |
| SCHEMBL10091341 | 0.75 | ESR2 (0.42) | ESR1ESR2HSD17B10ABL1ABCB1 | |
| SCHEMBL10458858 | 0.75 | PTGS1 (0.43) | ESR1ESR2HSD17B10ABL1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101095-B2 | Antiferroelectric orthoconic liquid crystalline material with long pitch and the method of its preparation | WOJSKOWA AKADEMIA TECHNICZNA IM. JAROSLAWA DABROWSKIEGO (PL) | 2012-01-24 | — | — | US | disclosed |
| US-8101095-B2 | Antiferroelectric orthoconic liquid crystalline material with long pitch and the method of its preparation | WOJSKOWA AKADEMIA TECHNICZNA IM. JAROSLAWA DABROWSKIEGO (PL) | 2012-01-24 | — | — | US | disclosed |
| US-20100258765-A1 | ANTIFERROELECTRIC ORTHOCONIC LIQUID CRYSTALLINE MATERIAL WITH LONG PITCH AND THE METHOD OF ITS PREPARATION | WOJSKOWA AKADEMIA TECHNICZNA IM. JAROSLAWA DABROWSKIEGO (PL) | 2010-10-14 | — | — | US | disclosed |
| US-20100258765-A1 | ANTIFERROELECTRIC ORTHOCONIC LIQUID CRYSTALLINE MATERIAL WITH LONG PITCH AND THE METHOD OF ITS PREPARATION | WOJSKOWA AKADEMIA TECHNICZNA IM. JAROSLAWA DABROWSKIEGO (PL) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100258765-A1 | ANTIFERROELECTRIC ORTHOCONIC LIQUID CRYSTALLINE MATERIAL WITH LONG PITCH AND THE METHOD OF ITS PREPARATION | CRY2, PAX2, CXXC5 | ESR1 4239/4885ESR2 3112/4885RPS6KA3 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.